Industry sources said CGS-CIMB may have decided to move out as they have not been able to scale up the business. With competition intensify...

ICRA expects securitisation volumes to touch an all-time high in this fiscal year.

Post the December quarter results, analysts have upped target of the oil-to-telecom major.

The stock fell 9.79% to hit a low of Rs 5,611.05 on the exchange. At the prevailing price, the stock is trading 25% lower than its 52-week ...

Elara Sec report says Tata Motors’ standalone business is expected to bleed at operating level yet again as volume crashed by 28%.

"Should a correction happen, it won't affect me because I know the market will give it much better valuations going ahead," says Irani.

Sharmila Joshi, Co-Head PCG Sales, Emkay Global Financial Services in an interview with ET Now fives her two stock picks.

Sharmila Joshi, Co-Head PCG Sales, Emkay Global Financial Services in an interview with ET Now talks about LIC Housing Finance.

Sharmila Joshi, Co-Head PCG Sales, Emkay Global Financial Services in an interview with ET Now talks about Jubilant Organosys.

Sharmila Joshi, Co-Head PCG Sales, Emkay Global Financial Services in an interview with ET Now talks about Jubilant Foodworks.

Sharmila Joshi, Co Head PCG Sales, Emkay Global Financial Services spoke to ET now on fertiliser stocks especially Deepak Fertilisers.

Sharmila Joshi, Co Head PCG Sales, Emkay Global Financial Services spoke to ET now on HBL Power and Gujarat Industries Power.

Sharmila Joshi, Co Head PCG Sales, Emkay Global Financial Services spoke to ET Now on Ipca Labs.

Sharmila Joshi, Co-Head PCG Sales, Emkay Global Financial Services talks to ET Now about IVRCL.

In a chat with ET Now, Sharmila Joshi, Co-head PCG Sales, Emkay Global Financial Services, talks about the outlook of Blue Star.

In a chat with ET Now, Sharmila Joshi, Co-head PCG Sales, Emkay Global Financial Services, talks about the outlook of Jubilant Organosys.

ET Now caught up with Sharmila Joshi, Co-Head PCG Sales, Emkay Global Financial Services, to get her views on the outlook of Torrent Pharma.